Jiangsu Hengrui Medicine
600276.SS
$6.12
Share price
1.37%
Change (1 day)
-12.70%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Market capitalization of Jiangsu Hengrui Medicine (600276.SS)
Market cap: $39.04 Billion
As of April 2024 Jiangsu Hengrui Medicine has a market cap of $39.04 Billion. This makes Jiangsu Hengrui Medicine the world's 496th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Jiangsu Hengrui Medicine from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $39.04 B | -3.96% |
| 2023 | $40.65 B | 15.36% |
| 2022 | $35.24 B | -30.77% |
| 2021 | $50.90 B | -44.14% |
| 2020 | $91.11 B | 64.44% |
| 2019 | $55.41 B | 96.2% |
| 2018 | $28.24 B | -5.06% |
| 2017 | $29.74 B | 93.44% |
| 2016 | $15.37 B | 3.71% |
| 2015 | $14.82 B | 62.88% |
| 2014 | $9.10 B | 6.64% |
| 2013 | $8.53 B | 42.99% |
| 2012 | $5.96 B | 13.8% |
| 2011 | $5.24 B | -22.29% |
| 2010 | $6.75 B | 41.48% |
| 2009 | $4.77 B | 63.18% |
| 2008 | $2.92 B | -12.7% |
| 2007 | $3.34 B | 144.13% |
| 2006 | $1.37 B | 194.2% |
| 2005 | $0.46 B | 21.19% |
| 2004 | $0.38 B | 48.64% |
| 2003 | $0.25 B | -16.33% |
| 2002 | $0.30 B | -28.92% |
| 2001 | $0.43 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Jiangsu Hengrui Medicine was reported to be:
